• Dijana Stojanovic, Valentina Mitic, Dejan Petrovic, Miodrag Stojanovic, Aleksandra Ignjatovic, Nikola Stefanovic, Tatjana Cvetkovic, Vladmila Bojanic, Gordana Kocic, and Ilic Marina Deljanin MD Institute for Treatment and Rehabilitation "Niska Banja", Srpskih junaka 2, 18205 Niška Banja, Serbia. .
• Institute of Pathophysiology, Faculty of Medicine, University of Nis, Dr. Zoran Djindjic Boulevard 81, 18000 Nis, Serbia.
• Dis. Markers. 2019 Jan 1; 2019: 7265160.

AbstractHeart failure represents a growing health problem, with increasing morbidity and mortality globally. According to the mechanisms involved in the pathogenesis of heart failure, many biomarkers have been proposed for the timely diagnosis and prognostication of patients with heart failure, but other than natriuretic peptides, none of them has gained enough clinical significance. Renalase, a new protein derived from kidneys was demonstrated to metabolize catecholamines and to have a cardioprotective role. The aim of the study was to determine whether renalase and brain natriuretic peptide (BNP) concentration could be used to differentiate heart failure patients stratified to the category of the ejection fraction and whether plasma renalase could be used as a biomarker for left ventricle hypertrophy in all subgroups of heart failure patients. We included patients diagnosed with heart failure and stratified them to the three subgroups according to the ejection fraction. Regarding echocardiographic parameters, HFmrEF had an intermediate profile in between HFrEF and HFpEF, with statistical significance in most evaluated parameters. BNP concentration was significantly different in all three subgroups (p < 0.001), and renalase was statistically higher in HFrEF (p = 0.007) compared to the HFmrEF and HFpEF, where its results were similar, without statistical significance. Renalase plasma concentration was demonstrated to be highly and positively associated with left ventricle mass index in HFrEF (p = 0.029), as well as increased plasma concentration of BNP (p = 0.006). In the HFmrEF group of patients, body mass index was positively associated with LVMI (p = 0.05), while in the patients with HFpEF, diabetes mellitus was demonstrated to have a positive association with LVMI (p = 0.043). These findings suggest that renalase concentration may be measured in order to differentiate patients with reduced ejection fraction. Plasma renalase concentrations positively correlated with left ventricle hypertrophy in patients with reduced ejection fraction, being strongly associated with increased left ventricular mass index.Copyright © 2019 Dijana Stojanovic et al.

23 keywords...

hide…